# Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

Study · id `cardio:ct-nct04363697` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04363697](<https://clinicaltrials.gov/study/NCT04363697>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04363697

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2401 participants.

## Technical summary

Registry record NCT04363697. Randomized; quadruple masking; primary purpose treatment. Start 2020-09-24 (actual); primary completion 2025-06-02 (actual). Results posted on 2026-06-16.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2401 participants (enrolled count; ClinicalTrials.gov record NCT04363697, source copy `cardio:ctgov-nct04363697-2026-06-16`, retrieved 2026-10-26)
- Started: 2020-09-24 (actual) (ClinicalTrials.gov record NCT04363697, source copy `cardio:ctgov-nct04363697-2026-06-16`, retrieved 2026-10-26)
- Primary completion: 2025-06-02 (actual) (ClinicalTrials.gov record NCT04363697, source copy `cardio:ctgov-nct04363697-2026-06-16`, retrieved 2026-10-26)
- Completion: 2025-06-02 (actual) (ClinicalTrials.gov record NCT04363697, source copy `cardio:ctgov-nct04363697-2026-06-16`, retrieved 2026-10-26)
- Results first posted: 2026-06-16 (ClinicalTrials.gov record NCT04363697, source copy `cardio:ctgov-nct04363697-2026-06-16`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04363697, source copy `cardio:ctgov-nct04363697-2026-06-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04363697-2026-06-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)
- Condition: Acute Heart Failure
- Condition: Heart Failure
- Intervention (Drug): Dapagliflozin
- Intervention (Drug): Placebo
- Lead sponsor: The TIMI Study Group
- Lead sponsor class: OTHER
- Collaborator: AstraZeneca
- Collaborator class: INDUSTRY
- Collaborator: Worldwide Clinical Trials
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry intervention name matches this record: Dapagliflozin (`cardio:dapagliflozin`)
- Registry intervention is a member of this class by a sourced record link: SGLT2 inhibitors (drug class) (`cardio:sglt2-inhibitors`)
- Registry lists this organization as the lead sponsor: The TIMI Study Group (`cardio:org-the-timi-study-group`)
- Registry lists this organization as a collaborator: AstraZeneca (`cardio:astrazeneca`)
- Registry lists this organization as a collaborator: Worldwide Clinical Trials (`cardio:org-worldwide-clinical-trials`)

## Provenance

Content hash: 65fa3b4cdc25427e0803ed63e1f1a1e64ccbf4a36d1785215fb1776fe5746474
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
